title: Therapeutic ritonavir-boosted atazanavir plasma concentration and concurrent omeprazole use.
authors.forename: Miguel
authors.initials: M
authors.lastname: Goicoechea
authors.forename: Brookie
authors.initials: B
authors.lastname: Best
authors.forename: Edmund
authors.initials: E
authors.lastname: Capparelli
authors.forename: Joseph
authors.initials: J
authors.lastname: Caperna
authors.forename: Craig
authors.initials: C
authors.lastname: Ballard
authors.forename: Richard
authors.initials: R
authors.lastname: Haubrich
mesh_terms: D019380:Anti-HIV Agents / Q000097:blood*; D023241:Antiretroviral Therapy, Highly Active; D000069446:Atazanavir Sulfate; D004347:Drug Interactions; D016903:Drug Monitoring / Q000379:methods; D015658:HIV Infections / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000097:blood*; D009853:Omeprazole / Q000494:pharmacology*; D054328:Proton Pump Inhibitors; D011725:Pyridines / Q000097:blood*; D019438:Ritonavir / Q000627:therapeutic use
chemical_list: D019380:Anti-HIV Agents; D009842:Oligopeptides; D054328:Proton Pump Inhibitors; D011725:Pyridines; D000069446:Atazanavir Sulfate; D009853:Omeprazole; D019438:Ritonavir